Phloretic Acid Improves Metabolic Dysfunction-Associated Steatotic Liver Disease in High-Fat Diet-Fed Mice
Molecules · 15.05.2026 · 31 (10) · 1681
DOI: 10.3390/molecules31101681 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecules, online erschienen am 15.05.2026. Verfasst von Sojeong Park und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Food Science and Nutrition, Pukyong National University, 45 Yongso-ro, Nam-gu, Busan 48513, Republic of Korea. Hauptthemen laut MEDLINE: Diet, High-Fat, Non-alcoholic Fatty Liver Disease, Fatty Liver, Metabolic Diseases. Die Arbeit nennt 67 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Research Foundation of Korea.
Abstract (Originalsprache)
Previous studies have demonstrated that phloretic acid (PA), a phenolic compound, exerts beneficial effects on inflammation, oxidative stress, and aging. However, its effects on obesity and associated metabolic abnormalities, including dyslipidemia and metabolic dysfunction-associated steatotic liver disease (MASLD), remain unclear. To evaluate the effects of PA on these obesity-related metabolic alterations and explore the underlying mechanisms, male C57BL/6J mice were divided into three groups and fed for 10 weeks with a low-fat diet (10 kcal% fat), a high-fat diet (HFD, 60 kcal% fat), or an HFD containing 0.02% (w/w) PA. PA-supplemented mice showed no significant weight loss and fat loss. However, PA supplementation significantly reduced circulating levels of free fatty acid, triglyceride, and non-high-density lipoprotein cholesterol (HDL-C) while increasing HDL-C levels in HFD-fed mice. It also reduced hepatic lipid deposition and alleviated hepatocellular injury. These effects were accompanied by the coordinated modulation of hepatic lipid metabolism, including reduced lipogenesis and cholesterol esterification, enhanced fatty acid oxidation, and increased bile acid synthesis and excretion. Furthermore, PA attenuated hepatic oxidative stress and suppressed systemic and hepatic inflammation. These observations suggest that PA may counteract HFD-induced MASLD by modulating hepatic lipid metabolism, and that its anti-inflammatory and antioxidant effects may also contribute to these metabolic improvements.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Food Science and Nutrition, Pukyong National University, 45 Yongso-ro, Nam-gu, Busan 48513, Republic of Korea.
ORCID-Profile: Sojeong Park, HwiCheol Kim, Un Ju Jung
Förderung
- National Research Foundation of Korea
Zitieren
APA
Park, S., Kim, H., & Jung, U. J. (2026). Phloretic Acid Improves Metabolic Dysfunction-Associated Steatotic Liver Disease in High-Fat Diet-Fed Mice. Molecules, 31(10), 1681. https://doi.org/10.3390/molecules31101681
Vancouver
Park S, Kim H, Jung UJ. Phloretic Acid Improves Metabolic Dysfunction-Associated Steatotic Liver Disease in High-Fat Diet-Fed Mice. Molecules. 2026;31(10):1681. doi:10.3390/molecules31101681
BibTeX
@article{Park2026,
author = {Park, Sojeong and Kim, HwiCheol and Jung, Un Ju},
title = {Phloretic Acid Improves Metabolic Dysfunction-Associated Steatotic Liver Disease in High-Fat Diet-Fed Mice},
journal = {Molecules},
year = {2026},
volume = {31},
number = {10},
pages = {1681},
doi = {10.3390/molecules31101681}
}
EUVIMED